Navigating the Gene Co-Expression Network and Drug Repurposing Opportunities for Brain Disorders Associated with Neurocognitive Impairment
Neurocognitive impairment refers to a spectrum of disorders characterized by a decline in cognitive functions such as memory, attention, and problem-solving, which are often linked to structural or functional abnormalities in the brain. While its exact etiology remains elusive, genetic factors play...
Main Authors: | Mathew Timothy Artuz Manuel, Lemmuel L. Tayo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/13/11/1564 |
Similar Items
-
Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases
by: Feng Yang, et al.
Published: (2021-01-01) -
Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposure
by: Seth M Dever, et al.
Published: (2015-07-01) -
Text-Mining Approach to Identify Hub Genes of Cancer Metastasis and Potential Drug Repurposing to Target Them
by: Trishna Saha Detroja, et al.
Published: (2022-04-01) -
Drug Repurposing Using Gene Co-Expression and Module Preservation Analysis in Acute Respiratory Distress Syndrome (ARDS), Systemic Inflammatory Response Syndrome (SIRS), Sepsis, and COVID-19
by: Ryan Christian Mailem, et al.
Published: (2022-12-01) -
Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
by: D. Vasile, et al.
Published: (2021-04-01)